Department of Health and Social Care

Employers have a key role to play in supporting workers with long-term health conditions or disabilities in the workplace and it is for employers to assess the training requirements for their workforce. However, the Department of Health and Social Care has no plans to introduce mandatory epilepsy training.

The Department for Work and Pensions’ current offer to employers includes a digital information service which provides tailored guidance to businesses to support employees, including epileptic employees, to remain in work.

The service was developed with user-centred design principles. It offers a simple, interactive, and highly usable resource which helps employers to feel more confident having conversations with their employees about health and disability as well as understanding and fulfilling their legal obligations.

This digital service provides tailored guidance on supporting employees in common workplace scenarios involving health and disability. This enables small businesses to self-serve, by guiding them through key processes. Employers are also able to access links to related government products and services as well as links to sources of external expert support including Epilepsy Action and Epilepsy Society.

The digital information service is available at the following link:

https://www.support-with-employee-health-and-disability.dwp.gov.uk/support-with-employee-health-and-disability

The Department of Health and Social Care is responsible for the overall delivery of the final delivery plan on myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). The Department funds research through the National Institute for Health and Care Research (NIHR).

To address the breadth of the ME/CFS research challenge, the NIHR and the Medical Research Council (MRC), part of UK Research and Innovation, play complementary roles in the United Kingdom landscape by funding research across the research system, with MRC funding aetiological and early-stage translational science and NIHR funding later stage translational and applied clinical work.

The NIHR and MRC are working together to deliver the research actions outlined in the ME/CFS final delivery plan that we published in July.

On 4 December 2025, we launched an independent review into the prevalence and support for mental health conditions, attention deficit hyperactivity disorder (ADHD), and autism. The review will look to understand the similarities and differences between mental health conditions, ADHD, and autism. It will look at the prevalence, early intervention and treatment, and the current challenges facing clinical services. It will also examine the extent to which diagnosis, medicalisation, and treatment improve outcomes for individuals. This will include exploring the evidence around clinical practice and the risks and benefits of medicalisation.

On 4 December 2025, we launched an independent review into the prevalence and support for mental health conditions, attention deficit hyperactivity disorder (ADHD), and autism. The review will look to understand the similarities and differences between mental health conditions, ADHD, and autism. It will look at the prevalence, early intervention and treatment, and the current challenges facing clinical services. It will also examine the extent to which diagnosis, medicalisation, and treatment improve outcomes for individuals. This will include exploring the evidence around clinical practice and the risks and benefits of medicalisation.

On 4 December 2025, we launched an independent review into the prevalence and support for mental health conditions, attention deficit hyperactivity disorder (ADHD), and autism. The review will look to understand the similarities and differences between mental health conditions, ADHD, and autism. It will look at the prevalence, early intervention and treatment, and the current challenges facing clinical services. It will also examine the extent to which diagnosis, medicalisation, and treatment improve outcomes for individuals. This will include exploring the evidence around clinical practice and the risks and benefits of medicalisation.

On 4 December 2025, we launched an independent review into the prevalence and support for mental health conditions, attention deficit hyperactivity disorder (ADHD), and autism. The review will look to understand the similarities and differences between mental health conditions, ADHD, and autism. It will look at the prevalence, early intervention and treatment, and the current challenges facing clinical services. It will also examine the extent to which diagnosis, medicalisation, and treatment improve outcomes for individuals. This will include exploring the evidence around clinical practice and the risks and benefits of medicalisation.

The independent review into prevalence and support for mental health conditions, attention deficit hyperactivity disorder (ADHD), and autism will appoint an advisory working group. This will be a multidisciplinary group of leading academics, clinicians, epidemiological experts, charities and people with lived experience to directly shape the recommendations and scrutinise the evidence.

Ahead of launching the independent review, my Rt Hon. Friend, the Secretary of State for Health and Social Care, held discussions with a range of mental health, ADHD, and autism stakeholders on the scope of the review.

As this is an independent review, it is therefore for the Chair and vice-chairs to consider who to consult and the relevant forums for engagement, that are relevant to deliver the terms of reference set by the Department.

The independent review into prevalence and support for mental health conditions, attention deficit hyperactivity disorder (ADHD), and autism will appoint an advisory working group. This will be a multidisciplinary group of leading academics, clinicians, epidemiological experts, charities and people with lived experience to directly shape the recommendations and scrutinise the evidence.

Ahead of launching the independent review, my Rt Hon. Friend, the Secretary of State for Health and Social Care, held discussions with a range of mental health, ADHD, and autism stakeholders on the scope of the review.

As this is an independent review, it is therefore for the Chair and vice-chairs to consider who to consult and the relevant forums for engagement, that are relevant to deliver the terms of reference set by the Department.

The independent review into prevalence and support for mental health conditions, attention deficit hyperactivity disorder (ADHD), and autism will appoint an advisory working group. This will be a multidisciplinary group of leading academics, clinicians, epidemiological experts, charities and people with lived experience to directly shape the recommendations and scrutinise the evidence.

Ahead of launching the independent review, my Rt Hon. Friend, the Secretary of State for Health and Social Care, held discussions with a range of mental health, ADHD, and autism stakeholders on the scope of the review.

As this is an independent review, it is therefore for the Chair and vice-chairs to consider who to consult and the relevant forums for engagement, that are relevant to deliver the terms of reference set by the Department.

The independent review into prevalence and support for mental health conditions, attention deficit hyperactivity disorder (ADHD), and autism will appoint an advisory working group. This will be a multidisciplinary group of leading academics, clinicians, epidemiological experts, charities and people with lived experience to directly shape the recommendations and scrutinise the evidence.

Ahead of launching the independent review, my Rt Hon. Friend, the Secretary of State for Health and Social Care, held discussions with a range of mental health, ADHD, and autism stakeholders on the scope of the review.

As this is an independent review, it is therefore for the Chair and vice-chairs to consider who to consult and the relevant forums for engagement, that are relevant to deliver the terms of reference set by the Department.

There are no supply issues regarding epidural insertion kits, but there are supply issues impacting some of the usual medicines used to provide pain relief via epidural infusion. However, a range of licensed and unlicensed bags, including unlicensed imports, remain available, and the situation is being closely monitored.

To ensure a system-wide co-ordinated approach on using these products and safe implementation, a National Patient Safety Alert was issued on 2 December 2025 with clear and comprehensive management guidance. The Department and NHS England have also worked with professional stakeholders to provide clinical advice for clinicians at hospital level to minimise potential disruption and maintain safe patient care, which is avaiable at the following link:

https://www.rcoa.ac.uk/sites/default/files/documents/2025-12/Epidural%20infusions%20vFinal_0.pdf

There are no current plans to review the list of prescription charge exemptions or the list of medical conditions that entitle someone to apply for a medical exemption certificate. There are no specific conditions that need to be met to trigger a formal review.

There are no current plans to review the list of prescription charge exemptions or the list of medical conditions that entitle someone to apply for a medical exemption certificate. There are no specific conditions that need to be met to trigger a formal review.

The Government has recognised that, nationally in England, demand for assessments for attention deficit hyperactivity disorder (ADHD) has grown significantly in recent years and that people are experiencing severe delays accessing such assessments. The Government’s 10-Year Health Plan for England will make the National Health Service fit for the future, recognising the need for early intervention and support.

It is the responsibility of integrated care boards (ICBs) in England to make appropriate provision to meet the health and care needs of their local population, including providing access to ADHD assessment and treatment, in line with relevant National Institute for Health and Care Excellence guidelines.

NHS England established an ADHD taskforce which brought together those with lived experience with experts from the NHS, education, charity, and justice sectors to get a better understanding of the challenges affecting those with ADHD, including in accessing timely and equitable access to services and support. We are pleased that the taskforce's final report was published on 6 November, and we are carefully considering its recommendations.

My Rt Hon. Friend, the Secretary of State for Health and Social Care, announced on 4 December 2025 the launch of an Independent Review into Prevalence and Support for Mental Health Conditions, ADHD and Autism. This independent review will inform our approach to enabling people with ADHD and autistic people to have the right support in place to enable them to live well in their communities.

It is for local integrated care boards to decide whether treatments such as cognitive behavioural therapy or digital solutions such as Sleepio should be offered to their local populations as a treatment for insomnia.

NHS Talking Therapies for anxiety and depression offer low-intensity therapy which may include interventions around sleep hygiene. Individuals who are experiencing symptoms of anxiety and/or depression can be referred by their general practitioner, or can self-refer, to NHS Talking Therapies. People can also access helpful resources on sleep problems on the Every Mind Matters website at the following link:

https://www.nhs.uk/every-mind-matters/mental-health-issues/sleep/

NHS England established an attention deficit hyperactivity disorder (ADHD) taskforce which brought together those with lived experience with experts from the National Health Service, education, charity, and justice sectors to get a better understanding of the challenges affecting those with ADHD, including in accessing timely and equitable access to services and support. We are pleased that the taskforce's final report was published on 6 November, and we are carefully considering its recommendations.

My Rt Hon. Friend, the Secretary of State for Health and Social Care, announced on 4 December 2025 the launch of an Independent Review into Prevalence and Support for Mental Health Conditions, ADHD and Autism. This independent review will inform our approach to enabling people with ADHD and autistic people to have the right support in place to enable them to live well in their communities.

National Health Service organisations must ensure that all patients have equitable access to care, and that decisions or policies do not unfairly disadvantage people or lead to an increase in inequalities. All NHS organisations are legally obliged to not discriminate against patients or staff.

This means that a non-digital solution should be available for those patients who cannot or do not wish to engage digitally, including those with mental health conditions or language barriers. These non-digital routes must be available for all services provided by NHS organisations.

Healthcare services in the prison estate are commissioned by NHS England. All prison healthcare providers are commissioned and contracted to use National Institute for Health and Care Excellence guidelines and have pathways of care in place for people refusing food and/or fluid. If a person requires hospital care this will also be available and facilitated.

I refer the hon. Member to the answer I gave on 8 January 2026 to Question 84380.

The Home Office, the Department for Education, and the Department of Health and Social Care issued multi-agency statutory guidance on female genital mutilation (FGM), which as updated in July 2020. The guidance ensures that health and other staff understand their role in responding to FGM, and that there are policies and procedures in place to protect women and girls who have undergone or are at risk of FGM.

NHS England is currently updating the e-learning training for the Healthcare FGM Module for publication in 2026. This training has a section on communication and includes the importance of sensitive language, including asking healthcare staff to check which terminology the woman or girl prefers. The training will provide healthcare staff with the skills to consider, recognise, and discuss FGM with the women and girls they support, and provide sensitive and trauma-informed response.

Decisions about recruitment are a matter for individual National Health Service employers, who manage this at a local level to ensure they have the staff they need to deliver safe and effective care.

Funding provided to NHS trusts is not ringfenced for specific items such as staffing levels. Hospitals receive funding allocations which they can use at their discretion, based on local priorities.

The 10 Year Workforce Plan will ensure that the NHS has the right people in the right places, with the right skills to care for patients, when they need it.

I refer the Hon. Member to the answer provided to him on 27 November 2025 to Question 92091 which set out the National Health Service’s Net Zero ambitions. Additionally, the answer provided to Queston 99799 on 22 December 2025 is clear that NHS England’s intent was to set ambitious but achievable aims that align with different sectoral pathways and expectations. This aims to support the United Kingdom’s overall approach to the statutory Net Zero target of 2050, which applies to the whole UK economy.

As per the 10-Year Health Plan, the Department is committed to supporting these ambitions, and we will do so in a way that delivers better value for money for the taxpayer and better care for patients, and which remains aligned to the Government's approach to carbon budgets and the overall Net Zero statutory target.

On 8 December 2025, the Government put an offer in writing to the British Medical Association Resident Doctors Committee which would put in place emergency legislation in the new year which would prioritise United Kingdom and Republic of Ireland medical graduates for foundation training, and prioritise UK and Republic of Ireland medical graduates and doctors who have worked in the National Health Service for a significant period of time for specialty training. This would apply to current applicants for training posts starting in 2026, and every year after that.

Other measures in the offer include creating 4,000 more specialty training places, with 1,000 of these brought forward to this year, cost related measures, such as reimbursement for exam fees, to address the unique costs that resident doctors face, and increasing the less than full time allowance by 50% to £1,500.

This is in addition to steps already taken by NHS England in September to tackle competition for speciality training places this year by changing General Medical Council registration requirements and limiting the number of applications that can be submitted by individuals.

We have also made significant progress over the past year to improve the working lives of resident doctors. This includes agreeing an improved exception reporting system which will ensure doctors are compensated fairly for additional work, reviewing how resident doctors rotate through their training, and reforming and rationalising statutory and mandatory training to reduce unnecessary burden and repetition.

In August 2025, NHS England published The NHS’s 10 Point Plan which set out actions for NHS England and trusts to improve resident doctors working conditions by fixing unacceptable working practices and getting the basics right for resident doctors. It aims to tackle basic issues like payroll errors, poor rota management, lack of access to rest facilities and hot food, and unnecessarily repeating training.

On 8 December 2025, the Government put an offer in writing to the British Medical Association Resident Doctors Committee which would put in place emergency legislation in the new year which would prioritise United Kingdom and Republic of Ireland medical graduates for foundation training, and prioritise UK and Republic of Ireland medical graduates and doctors who have worked in the National Health Service for a significant period of time for specialty training. This would apply to current applicants for training posts starting in 2026, and every year after that.

Other measures in the offer include creating 4,000 more specialty training places, with 1,000 of these brought forward to this year, cost related measures, such as reimbursement for exam fees, to address the unique costs that resident doctors face, and increasing the less than full time allowance by 50% to £1,500.

This is in addition to steps already taken by NHS England in September to tackle competition for speciality training places this year by changing General Medical Council registration requirements and limiting the number of applications that can be submitted by individuals.

We have also made significant progress over the past year to improve the working lives of resident doctors. This includes agreeing an improved exception reporting system which will ensure doctors are compensated fairly for additional work, reviewing how resident doctors rotate through their training, and reforming and rationalising statutory and mandatory training to reduce unnecessary burden and repetition.

In August 2025, NHS England published The NHS’s 10 Point Plan which set out actions for NHS England and trusts to improve resident doctors working conditions by fixing unacceptable working practices and getting the basics right for resident doctors. It aims to tackle basic issues like payroll errors, poor rota management, lack of access to rest facilities and hot food, and unnecessarily repeating training.

On 8 December 2025, the Government put an offer in writing to the British Medical Association Resident Doctors Committee which would put in place emergency legislation in the new year which would prioritise United Kingdom and Republic of Ireland medical graduates for foundation training, and prioritise UK and Republic of Ireland medical graduates and doctors who have worked in the National Health Service for a significant period of time for specialty training. This would apply to current applicants for training posts starting in 2026, and every year after that.

Other measures in the offer include creating 4,000 more specialty training places, with 1,000 of these brought forward to this year, cost related measures, such as reimbursement for exam fees, to address the unique costs that resident doctors face, and increasing the less than full time allowance by 50% to £1,500.

This is in addition to steps already taken by NHS England in September to tackle competition for speciality training places this year by changing General Medical Council registration requirements and limiting the number of applications that can be submitted by individuals.

We have also made significant progress over the past year to improve the working lives of resident doctors. This includes agreeing an improved exception reporting system which will ensure doctors are compensated fairly for additional work, reviewing how resident doctors rotate through their training, and reforming and rationalising statutory and mandatory training to reduce unnecessary burden and repetition.

In August 2025, NHS England published The NHS’s 10 Point Plan which set out actions for NHS England and trusts to improve resident doctors working conditions by fixing unacceptable working practices and getting the basics right for resident doctors. It aims to tackle basic issues like payroll errors, poor rota management, lack of access to rest facilities and hot food, and unnecessarily repeating training.

On 8 December 2025, the Government put an offer in writing to the British Medical Association Resident Doctors Committee which would put in place emergency legislation in the new year which would prioritise United Kingdom and Republic of Ireland medical graduates for foundation training, and prioritise UK and Republic of Ireland medical graduates and doctors who have worked in the National Health Service for a significant period of time for specialty training. This would apply to current applicants for training posts starting in 2026, and every year after that.

Other measures in the offer include creating 4,000 more specialty training places, with 1,000 of these brought forward to this year, cost related measures, such as reimbursement for exam fees, to address the unique costs that resident doctors face, and increasing the less than full time allowance by 50% to £1,500.

This is in addition to steps already taken by NHS England in September to tackle competition for speciality training places this year by changing General Medical Council registration requirements and limiting the number of applications that can be submitted by individuals.

We have also made significant progress over the past year to improve the working lives of resident doctors. This includes agreeing an improved exception reporting system which will ensure doctors are compensated fairly for additional work, reviewing how resident doctors rotate through their training, and reforming and rationalising statutory and mandatory training to reduce unnecessary burden and repetition.

In August 2025, NHS England published The NHS’s 10 Point Plan which set out actions for NHS England and trusts to improve resident doctors working conditions by fixing unacceptable working practices and getting the basics right for resident doctors. It aims to tackle basic issues like payroll errors, poor rota management, lack of access to rest facilities and hot food, and unnecessarily repeating training.

We have committed to updating workforce modelling which will be set out in and alongside the 10 Year Workforce Plan when published in spring 2026. This will be supported by external scrutiny to independently assess and test it.

We have committed to updating workforce modelling which will be set out in and alongside the 10 Year Workforce Plan when published in spring 2026. This will be supported by external scrutiny to independently assess and test it.

Dedicated and protected surgical hubs transform the way the National Health Service provides elective care by focusing on providing high volume, low complexity surgery, as recommended by the Royal College of Surgeons of England.

There are currently 123 elective surgical hubs that are operational across England.

We are working on delivering six additional hubs, five of which are currently expected to open in the next 12 months.

The Department is committed to ramping up the number of hubs over the next three years, so more operations can be carried out.

We are working with NHS England to implement the recommendations from the Cass Review to ensure everyone gets the high-quality care they need. This includes setting up a clinical pathway and provision for people considering detransition.

On 30 October 2025, NHS England published a call for evidence on a clinical pathway for adults who have previously undergone a gender transition and who wish to detransition. The call for evidence closes on 28 December 2025

NHS England is considering all relevant feedback that has been submitted. It will collate views, evidence and insights into a summary evidence report.

NHS England will use this evidence, together with other intelligence and further engagement, to begin to define a clinical pathway which will be tested through further stakeholder engagement and public consultation in 2025/26.

Publication of the 2023 abortion statistics has been pre-announced for 15 January 2026 and will be published on the GOV.UK website.

We will announce the exact date for publication of the 2024 abortion statistics in due course.

The Data Linkage Study is a retrospective study based on an analysis of data collected historically for a cohort of adults who, as children, were cared for under a former model of National Health Service gender care, the Gender Identity Development Service (GIDS). This study requires no active patient participation and instead relies on an analysis of the available digital information held within health records and other nationally held databases. The analysis looks for potential linkages or associations that do not prove ‘cause and effect’ but nonetheless may provide useful insights on the experience and outcomes of former GIDS patients.

The study was planned to take place during the lifespan of the Independent Cass Review and a statutory instrument was brought forward in 2022 aiming to protect those disclosing protected information. It is well documented that some NHS adult Gender Dysphoria Clinics did not send data to allow the study to commence and the study was not completed.

NHS England is now responsible for delivery of the Data Linkage Study. NHS England has taken time to undertake due diligence work on the data sources critical to the study, and to work with organisations to refine the planned approach to data sharing. Study approvals are currently in progress. As with usual research practice, the data linkage study protocol will be made available in the public domain once independent research and ethical approvals have been appropriately secured, at which point the analytical work can begin.

The Food Standards Agency’s (FSA) review of nitrates and nitrites as food additives is an important piece of work that summarises recent evidence from human studies to inform policy decisions.

To maintain transparency, the full report, including its scope, search criteria, and details of the external contract, has been published on Government websites. This allows stakeholders and the public to see exactly how the review was conducted and how conclusions were reached.

The published report clearly sets out the methodology and criteria used, providing clarity and confidence in the process. The FSA does not routinely publish internal correspondence or preparatory communications, due to the potential inclusion of commercially sensitive or personal information. However, the report itself provides full transparency on the evidence base and decision-making approach. There have been no discussions on changing this approach.

There are no plans to commission a broader multidisciplinary study. Existing permitted nitrite levels are based on robust international risk assessments and remain appropriate to protect public health. Commissioning a new study would require significant resource and is not justified without new evidence indicating a change in risk.

NHS England is responsible for delivery of the Data Linkage Study. It is a retrospective study based on an analysis of data collected historically for a cohort of adults who, as children, were cared for under a former model of National Health Service gender care, the Gender Identity Development Service (GIDS). This study requires no active patient participation and instead relies on an analysis of the available digital information held within health records and other nationally held databases. The analysis will look for potential linkages or associations that do not prove ‘cause and effect’ but nonetheless may provide useful insights on the experience and outcomes of former GIDS patients.

NHS England has taken time to undertake due diligence work on the data sources critical to the study, and to work with organisations to refine the planned approach to data sharing. Study approvals are currently in progress. As with usual research practice, the Data Linkage Study protocol will be made available in the public domain once independent research and ethical approvals have been appropriately secured, at which point the analytical work can begin.

The Department is working with NHS England to support local systems to deliver effective rehabilitation and prehabilitation services. The National Cancer Plan will aim to improve how the physical and psychosocial needs of people with cancer can be met, with a focus on personalised care to improve quality of life. It will address how the experience of care can be improved for those diagnosed, treated, and living with and beyond cancer.

As set out in the Men’s Health Strategy, we have committed to a range of actions to improve men’s health literacy, from building the evidence base to identifying ways to build media and health literacy skills in men.

We are now turning our focus to implementing these commitments. We will consider the evidence base on anabolic steroids and image and performance enhancing drugs in defining the scope of our actions.

By investing in innovative, evidence-based, and locally led community programs, we aim to address health inequalities, improve health literacy, and challenge societal norms that may hinder men from seeking care. This targeted approach lays the foundation for long-term, meaningful change in men's health outcomes.

Postural orthostatic tachycardia syndrome (PoTS) is diagnosed by a combination of general practitioners (GPs) and specialist clinicians. GPs can diagnose PoTS in many cases but, if they are unsure of symptoms or if symptoms are complex, they will refer patients to specialists for diagnosis, or where patients do not respond to initial treatment, patients may be referred to specialised cardiology or neurology services. The Royal College of General Practitioners’ Syncope Toolkit provides information to GPs, including the use of the active stand test, to rule out other conditions and potentially diagnose PoTS more quickly. Management of PoTS typically involves lifestyle changes and medications to help control symptoms, and can involve support from a multidisciplinary team.

Where patients are referred to secondary care for diagnosis, we are investing in additional capacity to deliver appointments to help bring waiting lists and times down. The Elective Reform Plan, published in January 2025, sets out the specific productivity and reform efforts needed to return to the constitutional standard, that 92% of patients to wait no longer than 18 weeks from referral to treatment, by March 2029.

By expanding community-based services for routine monitoring and follow up, employing artificial intelligence for productivity, and investing in digital tools and data, as outlined in the 10-Year Health Plan, we can ensure that consultants’ time is reserved for complex cases of PoTS, including specialist diagnostic assessments.

Integrated care boards (ICBs), with oversight from NHS England, have a statutory responsibility to commission services which meet the needs of their local populations, including for those with PoTS. It is the responsibility of ICBs to work with clinicians, service users, and patient groups to develop services and care pathways that meet the needs of patients with PoTS. While the Department recognises the significant challenges of PoTS diagnoses, responsibility for specific clinical pathways and specialist training rests with local National Health Service bodies.

The Department has made no assessment of the impact of NHS policies on private access for patients with PoTS seeking faster access to specialist care.

Postural orthostatic tachycardia syndrome (PoTS) is diagnosed by a combination of general practitioners (GPs) and specialist clinicians. GPs can diagnose PoTS in many cases but, if they are unsure of symptoms or if symptoms are complex, they will refer patients to specialists for diagnosis, or where patients do not respond to initial treatment, patients may be referred to specialised cardiology or neurology services. The Royal College of General Practitioners’ Syncope Toolkit provides information to GPs, including the use of the active stand test, to rule out other conditions and potentially diagnose PoTS more quickly. Management of PoTS typically involves lifestyle changes and medications to help control symptoms, and can involve support from a multidisciplinary team.

Where patients are referred to secondary care for diagnosis, we are investing in additional capacity to deliver appointments to help bring waiting lists and times down. The Elective Reform Plan, published in January 2025, sets out the specific productivity and reform efforts needed to return to the constitutional standard, that 92% of patients to wait no longer than 18 weeks from referral to treatment, by March 2029.

By expanding community-based services for routine monitoring and follow up, employing artificial intelligence for productivity, and investing in digital tools and data, as outlined in the 10-Year Health Plan, we can ensure that consultants’ time is reserved for complex cases of PoTS, including specialist diagnostic assessments.

Integrated care boards (ICBs), with oversight from NHS England, have a statutory responsibility to commission services which meet the needs of their local populations, including for those with PoTS. It is the responsibility of ICBs to work with clinicians, service users, and patient groups to develop services and care pathways that meet the needs of patients with PoTS. While the Department recognises the significant challenges of PoTS diagnoses, responsibility for specific clinical pathways and specialist training rests with local National Health Service bodies.

The Department has made no assessment of the impact of NHS policies on private access for patients with PoTS seeking faster access to specialist care.

Postural orthostatic tachycardia syndrome (PoTS) is diagnosed by a combination of general practitioners (GPs) and specialist clinicians. GPs can diagnose PoTS in many cases but, if they are unsure of symptoms or if symptoms are complex, they will refer patients to specialists for diagnosis, or where patients do not respond to initial treatment, patients may be referred to specialised cardiology or neurology services. The Royal College of General Practitioners’ Syncope Toolkit provides information to GPs, including the use of the active stand test, to rule out other conditions and potentially diagnose PoTS more quickly. Management of PoTS typically involves lifestyle changes and medications to help control symptoms, and can involve support from a multidisciplinary team.

Where patients are referred to secondary care for diagnosis, we are investing in additional capacity to deliver appointments to help bring waiting lists and times down. The Elective Reform Plan, published in January 2025, sets out the specific productivity and reform efforts needed to return to the constitutional standard, that 92% of patients to wait no longer than 18 weeks from referral to treatment, by March 2029.

By expanding community-based services for routine monitoring and follow up, employing artificial intelligence for productivity, and investing in digital tools and data, as outlined in the 10-Year Health Plan, we can ensure that consultants’ time is reserved for complex cases of PoTS, including specialist diagnostic assessments.

Integrated care boards (ICBs), with oversight from NHS England, have a statutory responsibility to commission services which meet the needs of their local populations, including for those with PoTS. It is the responsibility of ICBs to work with clinicians, service users, and patient groups to develop services and care pathways that meet the needs of patients with PoTS. While the Department recognises the significant challenges of PoTS diagnoses, responsibility for specific clinical pathways and specialist training rests with local National Health Service bodies.

The Department has made no assessment of the impact of NHS policies on private access for patients with PoTS seeking faster access to specialist care.

Delivering integrated, joined-up health, education, and family support is at the heart of our ambition to raise the healthiest generation of children ever.

Healthy Babies, formerly Start for Life, funding is helping families during the critical 1,001 days, and parents have said that they are more confident in feeding their babies and have better perinatal mental health because of this support. Further information is available at the following link:

https://www.gov.uk/government/publications/start-for-life-services-thematic-review/start-for-life-services-thematic-review

We continue to assess how we can best support early years service integration across the country and remain committed to working with delivery partners locally to achieve this.

Healthy Babies is one element of our broader commitment to supporting babies, children, and families. From April 2026, Best Start Family Hubs will expand to every single local authority, backed by over £500 million, to reach up to half a million more children and families. This funding will help all local authorities to integrate a range of statutory and non-statutory child health and family services.

Best Start Family Hubs will form part of the architecture of the Neighbourhood Health Service. Through the shifts from hospital to community and from treatment to prevention, we will further strengthen the integration of services, helping to ensure that babies and their families can get the support they need, when and where they need it.

The National Cancer Plan will build on the shift from hospital to community set out by the 10-Year Health Plan and will seek to foster improved collaboration with the voluntary and community sector to deliver this.

Governance mechanisms for monitoring implementation and ensuring accountability for delivery will be established as part of the development of the National Cancer Plan, which will be published in the new year.

Initially, the Diagnosis Connect Service will be piloted across a small number of long-term conditions which will be determined based on conditions diagnosed and referred from primary care, and readiness of the charities to proceed, as well as considerations around which diagnostic pathways might most benefit from this approach.

The aim will be to focus more support going to those with greatest need and areas with the worst health outcomes, therefore impacting on inequalities.

An open procurement process will enable us to secure a partnership with three or more specialist charities which have the infrastructure, capabilities, and networks to deliver a successful pilot for patients and the National Health Service, ahead of a full rollout across the wider health system.

Research is crucial in tackling cancer, which is why the Department invests over £1.6 billion per year in research through the National Institute for Health and Care Research (NIHR). Cancer is a major area of NIHR spending at £141.6 million in 2024/25, reflecting its high priority. Research is a key focus of the National Cancer Plan. The plan will seek to ensure advances in cancer research benefit patients across the country, including the North of England.

The Department is committed to funding health and care research via the NIHR across England, to ensure that the research we support is inclusive and representative of the populations we serve.

NIHR research infrastructure has national coverage across the whole of England across all geographies and settings. Our infrastructure schemes aim to build research capacity and capability across the country across all geographies and settings. In line with prior commitments, the Department has increased funding for research infrastructure schemes delivering cancer research in northern regions, including Biomedical Research Centres, Clinical Research Facilities, and HealthTech Research Centres.

Through the NIHR Research Delivery Network, the NIHR provides funding and support to the National Health Service and other providers to deliver research, operating across 12 regions throughout the country. The North West, North East and North Cumbria, and Yorkshire and Humber Regional Research Delivery Networks operate in all NHS trusts that span the north of England, giving researchers and delivery teams the practical support they need locally so that more research can take place, and more people can take part.

NHS England supports local integrated care boards to deliver high-quality, timely services through initiatives such as the Getting It Right First Time (GIRFT) programme.

As part of its work within the gastroenterology specialty, GIRFT is sharing a template and best practice for the use of advice and guidance, and advice and referencing to promote earlier diagnosis, and is also encouraging the use of single point of access models, which can help patients get earlier access to specialist opinions, advice, and treatment.

GIRFT has also recently published a new inflammatory bowel disease (IBD) handbook pulling together examples of innovative practice, proven solutions, and practical actions to help optimise the care of National Health Service patients with IBD. The GIRFT IBD pathway and associated handbook include specific guidance for paediatric care and transition to adult services, recognising the unique needs of children and young people with Crohn’s disease and ulcerative colitis. The handbook is available at the following link:

https://gettingitrightfirsttime.co.uk/practical-advice-and-key-actions-in-new-girft-handbook-for-optimising-the-care-of-patients-with-ibd/

GIRFT is also working with providers on a Further Faster Follow-Up programme, which introduces key protocols for gastroenterology, with IBD and suspected IBD being included, and is also collaborating on national work to develop a digital IBD pathway. It is too early to assess the effectiveness of these initiatives.